Le Lézard
Classified in: Health
Subject: PER

Norbert Oppitz Joins Sobitm as New Senior Vice President, Specialty Care



STOCKHOLM, Oct. 6, 2017 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobitm) today announces that Norbert Oppitz has been appointed Senior Vice President for the newly established business area Specialty Care.

Norbert Oppitz brings considerable management experience from over 30 years in the Pharmaceutical and Healthcare Industry. Most recently he has been a member of the Executive Committee of BSN Medical in charge of Latin America. Beforehand, he was a member of the Executive Committee of Endo Pharmaceuticals where he was in charge of emerging markets. In previous capacities, he has led large organisations as Head of Latin America at Takeda/Nycomed as well as in country management roles at Roche Pharmaceuticals and Aventis Pharma.

"We are delighted that Norbert could join Sobi. Norbert is a true entrepreneur, and his experience will be instrumental in realising our ambitions to bring Sobi to the next level as we look for external growth opportunities for our Specialty Care business," says Guido Oelkers, President and CEO of Sobi.

Norbert Oppitz will head Sobi's Specialty Care organisation and work closely together with Corporate Development and the regional and country organisations. Norbert will be part of Sobi's Executive Leadership Team.

"I am excited to join Sobi ? a company with a strong, patient-centric profile and a great potential. I look forward to contributing to the future growth of the company by realising a strategy to build and develop a strong and vital Specialty Care business unit," says Norbert.

Norbert Oppitz joined Sobi on 2 October 2017.

About Sobitm

Sobitm is an international speciality healthcare company dedicated to rare diseases. Our mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. We also market a portfolio of speciality and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2016, Sobi had total revenues of SEK 5.2 billion (USD 608 M) and approximately 760 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com

For more information please contact 

 Media relations

Investor relations

 Linda Holmström, Senior Communications Manager

Jörgen Winroth, Vice President, Head of Investor Relations

+46-70-873-40-95

+1-347-224-0819, +1-212-579-0506

 linda.holmstrom@sobi.com 

jorgen.winroth@sobi.com 

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/swedish-orphan-biovitrum-ab/r/norbert-oppitz-joins-sobi--as-new-senior-vice-president--specialty-care,c2361681

The following files are available for download:

SOURCE Swedish Orphan Biovitrum AB


These press releases may also interest you

at 04:00
CLEVELAND, Ohio, April 22, 2018 /PRNewswire-PRWeb/ -- In honor of National Adopt a Shelter Pet Day on April 30th, Embrace Pet Insurance is responding to common shelter pet misconceptions. Common Shelter Pet Misconceptions: 1. You can't find a...

21 avr 2018
People with tremors in their hands from a condition called essential tremor may find some relief from a new, non-invasive type of nerve stimulation, according to a preliminary scientific abstract released today that will be presented at the American...

21 avr 2018
Promius Pharma LLC announces its presentations for the 70th American Academy of Neurology (AAN) Annual Meeting in Los Angeles, CA, April 21-27, 2018. Promius will present 3 platform presentations, with one presentation selected for the "Best of"...

21 avr 2018
Global pharmaceutical company Mylan N.V. today announced three scientific abstracts from the Glatiramer Acetate development program will be presented at the American Academy of Neurology (AAN) 70th Annual Meeting in Los Angeles, April 21-27. The...

21 avr 2018
Laborie Medical Technologies ("Laborie") announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. ("Merger Sub"), a wholly owned subsidiary of LM US Parent, Inc. ("Parent") to purchase all outstanding shares of...

21 avr 2018
Injured veterans and their guests enjoyed the last days of winter as they gathered with other warriors to ski cross-country with Wounded Warrior Project® (WWP). "We liked it so much, we're planning on going back on our...




News published on 6 october 2017 at 02:28 and distributed by: